Federal regulators brushed off for nearly two years the ethical qualms that officials at a sister agency had about the experimental use of a blood substitute given without consent to trauma patients, a lawmaker said Monday.
Federal regulators brushed off for nearly two years the ethical qualms that officials at a sister agency had about the experimental use of a blood substitute given without consent to trauma patients, a lawmaker said Monday.
